Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

17.77
+0.52003.01%
Pre-market: 18.150.3800+2.14%05:07 EDT
Volume:11.58M
Turnover:204.00M
Market Cap:20.38B
PE:-15.55
High:17.83
Open:17.58
Low:17.34
Close:17.25
Loading ...
Aug 07, 2019

Major Issues Report

Current report, item 5.02
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Major Issues Report

Current report, item 5.07
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 02, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 02, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Apr 16, 2018

Correspondence

Apr 16, 2018

Correspondence

Apr 16, 2018

Correspondence